PA
IOVA icon

Parallel Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Parallel Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17K Buy
+332
New +$1.06K ﹤0.01% 3509
2025
Q3 		– Sell
-86
Closed -$148 – 3625
2025
Q2 		$148 Hold
86
– – ﹤0.01% 3436
2025
Q1 		$286 Sell
86
-251
-74% -$1.29K ﹤0.01% 3334
2024
Q4 		$2.49K Buy
337
+153
+83% +$1.42K ﹤0.01% 2895
2024
Q3 		$1.73K Sell
184
-129
-41% -$1.22K ﹤0.01% 2919
2024
Q2 		$2.51K Buy
313
+205
+190% +$2.2K ﹤0.01% 2743
2024
Q1 		$1.6K Hold
108
– – ﹤0.01% 2857
2023
Q4 		$878 Sell
108
-477
-82% -$2.5K ﹤0.01% 2965
2023
Q3 		$2.66K Buy
585
+384
+191% +$2.51K ﹤0.01% 2726
2023
Q2 		$1.42K Sell
201
-35
-15% -$251 ﹤0.01% 2850
2023
Q1 		$1.44K Buy
236
+16
+7% +$110 ﹤0.01% 2864
2022
Q4 		$1.41K Sell
220
-316
-59% -$2.47K ﹤0.01% 2808
2022
Q3 		$5K Buy
536
+26
+5% +$300 ﹤0.01% 2299
2022
Q2 		$6K Buy
510
+252
+98% +$3.3K ﹤0.01% 2184
2022
Q1 		$4K Sell
258
-395
-60% -$6.11K ﹤0.01% 2375
2021
Q4 		$12K Sell
653
-37
-5% -$815 ﹤0.01% 2031
2021
Q3 		$17K Buy
690
+334
+94% +$7.87K ﹤0.01% 1824
2021
Q2 		$9K Buy
356
+277
+351% +$7.2K ﹤0.01% 2049
2021
Q1 		$3K Buy
79
+34
+76% +$1.41K ﹤0.01% 2375
2020
Q4 		$2K Hold
45
– – ﹤0.01% 2316
2020
Q3 		$1K Hold
45
– – ﹤0.01% 2447
2020
Q2 		$1K Buy
+45
New +$1.48K ﹤0.01% 2329

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Parallel Advisors's IOVA Position: Q1 2026 in Review

Parallel Advisors opened a new position in Iovance Biotherapeutics (IOVA) in Q1 2026: 332 shares worth $1.17K. The stake represents ﹤0.01% of the portfolio and ranks #3509 among its holdings. This is a return to the name: Parallel Advisors previously reported a position in IOVA as recently as Q2 2025.

Parallel Advisors first reported a position in IOVA in Q2 2020 and has held it in 22 quarters since. The position peaked at $17K in Q3 2021. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Parallel Advisors held 332 shares of Iovance Biotherapeutics worth $1.17K as of Q1 2026.
  • Iovance Biotherapeutics was a new Parallel Advisors position in Q1 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #3509 holding.
  • Parallel Advisors first reported a position in Iovance Biotherapeutics in Q2 2020 and has held it in 22 quarters since.
  • Parallel Advisors's Iovance Biotherapeutics position peaked at $17K in Q3 2021.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.